Evidence map›Paper›PMID 39542005›Full record

ReviewThe Lancet. Rheumatology2024

Understanding the multiple dimensions of ageing: 5Ms for the rheumatologist.

Bjoern Buehring, Marloes van Onna, Elena Myasoedova, Jiha Lee, Una E Makris

Abstract readReview
In one paragraph

Review in The Lancet. Rheumatology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Reply.ACR open rheumatology · 2025
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Bjoern BuehringBergisches Rheuma-Zentrum, Krankenhaus St Josef, Wuppertal, Germany; Rheumazentrum Ruhrgebiet, Ruhr-University Bochum, Bochum, Germany.
Marloes van OnnaDepartment of Medicine, Division of Rheumatology, Maastricht University Medical Center, Maastricht, Netherlands; School for Public Health and Primary Care, Maastricht University, Maastricht, Netherlands.
Elena MyasoedovaDivision of Rheumatology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA; Division of Epidemiology, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.
Jiha LeeDivision of Rheumatology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.
Una E MakrisDivision of Rheumatic Diseases, Department of Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA; Division of Rheumatology, Dallas Veterans Affairs Medical Center, Veterans Affairs North Texas Health Care System, Dallas, TX, USA. Electronic address: una.makris@utsouthwestern.edu.

Funding

Pilot CoreP30AG022845 · NIA · WEILL MEDICAL COLL OF CORNELL UNIV · PI Manney Carrington Reid · 2003 to 2026
$15.2M
Role of Systemic Inflammation in Cognitive Decline: Rheumatoid Arthritis as a PrototypeR01AG068192 · NIA · MAYO CLINIC ROCHESTER · PI Elena Myasoedova · 2020 to 2026
$4.4M
Temporal associations between systemic inflammation, cardiovascular risk profile and development of Alzheimer’s disease and related dementias in patients with rheumatoid arthritisK24AG078179 · NIA · MAYO CLINIC ROCHESTER · PI Elena Myasoedova · 2022 to 2026
$951k
Understanding disease modifying antirheumatic drug use in older adults with late-onset rheumatoid arthritisK23AG082727 · NIA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI JIHA LEE · 2023 to 2026
$778k
Evaluation of treatment patterns and prescription medication use among older adults with late-onset rheumatoid arthritisR03AG067975 · NIA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LEE, JIHA · 2020 to 2021
$308k
HSRD VA I01 HX003350NIA NIH HHS K23 AG082727NIA NIH HHS K24 AG078179NIA NIH HHS P30 AG022845NIA NIH HHS R01 AG068192NIA NIH HHS R03 AG067975
6 · The paper itself

Abstract

The global population is ageing and the rheumatology workforce should be prepared to take care of the inevitable complexities of ageing patients. We can learn from our colleagues and experts in geriatrics about how best to manage multimorbidity, polypharmacy, geriatric syndromes, and shifting priorities of older patients in the context of delivering care for rheumatic diseases. One approach to learning and adopting key ageing constructs within rheumatology practice is to incorporate the established Geriatric 5Ms-principles fundamental to caring for older adults. In this Series paper we discuss the 5Ms in the context of rheumatology practice (1) multicomplexity: assessing and managing multimorbidity and challenging biopsychosocial situations, (2) medications: ensuring that medications do not interfere with the other Ms, (3) mind: managing neurocognitive disorders and comorbid mental health conditions, (4) mobility: ensuring older adults can move independently and safely, and (5) what matters most: aligning care with an older adult's specific goals.

Indexed as

AgingAgedGeriatricsHumansMultimorbidityPolypharmacyRheumatic DiseasesRheumatologistsRheumatology

Identifiers

PMID39542005
PMCPMC11831986

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.